What is Travere Therapeutics, Inc.'s investing cash flow?

Travere Therapeutics, Inc. (TVTX) reported investing cash flow of $21.55M in Q1 2026.

How has Travere Therapeutics, Inc.'s investing cash flow changed year-over-year?

Travere Therapeutics, Inc.'s investing cash flow decreased by 47.8% year-over-year, from $41.29M to $21.55M.

What does investing cash flow mean?

Total net cash provided by or used in investing activities — capex, acquisitions, investment purchases/sales, and other investing items.

Travere Therapeutics, Inc. TVTX Investing Cash Flow

Investing Cash Flow at other companies

Vertex PharmaceuticalsVRTX

-$431.9M-674%

Vera TherapeuticsVERA

-$137.82M-1,000%

LQD

Liquidia CorporationLQDA

-$2.83M-758%

Ultragenyx PharmaceuticalRARE

-$49M-141%

BridgeBio PharmaBBIO

-$42.74M-2,579%

PVL

Palvella TherapeuticsPVLA

-$55.44M—

Other financials

Income statement

See full

Revenue$127.2M+55.6%

Gross profit$125.2M+62.5%

Operating income-$36.9M+13.5%

Net income-$37.1M+10.0%

EPS (diluted)-$0.40+14.9%

Balance sheet

See full

Cash & equivalents$78.4M+26.6%

Total debt$15.6M-82.6%

Total equity$98.7M+201%

Total assets$555.2M+1.2%

Cash flow

See full

Operating cash flow-$40.4M+4.3%

CapEx$140.0K—

Free cash flow-$42.5M+28.1%

Valuation

See full

Market cap$5.2B+72.3%

Profitability

See full

Gross margin98.6%+2.6pp

Operating margin-10.6%-5.0pp

Net margin-20.3%-9.5pp

FCF margin-133.9%-34.4pp

Returns & leverage

See full

Return on equity-706%-1,302pp

Debt / equity0.2×-2.6×

Current ratio3.1×+1.1×

Where this comes from

Reported directly by Travere Therapeutics, Inc. in its filing.

Tagged under the XBRL concept us-gaap:NetCashProvidedByUsedInInvestingActivities.

The official record: Travere Therapeutics, Inc.’s 10-Q, filed May 4, 2026, on SEC EDGAR. View the filing →

Ask your AI about Travere Therapeutics, Inc.'s investing cash flow.

Connect your AI assistant and compare it to peers, right in your chat.

Connect your AI

Claude

Questions, answered.

What is Travere Therapeutics, Inc.'s investing cash flow?: Travere Therapeutics, Inc. (TVTX) reported investing cash flow of $21.55M in Q1 2026.
How has Travere Therapeutics, Inc.'s investing cash flow changed year-over-year?: Travere Therapeutics, Inc.'s investing cash flow decreased by 47.8% year-over-year, from $41.29M to $21.55M.
What does investing cash flow mean?: Total net cash provided by or used in investing activities — capex, acquisitions, investment purchases/sales, and other investing items.